CA Patent

CA1334092C — Angiotensin ii receptor blocking imidazoles

Assigned to EIDP Inc · Expires 1995-01-24 · 31y expired

What this patent protects

Substituted imidazoles such as are useful as angiotensin II blockers. These compounds have activity in treating hypertension and congestive heart failure.

USPTO Abstract

Substituted imidazoles such as are useful as angiotensin II blockers. These compounds have activity in treating hypertension and congestive heart failure.

Drugs covered by this patent

Patent Metadata

Patent number: CA1334092C
Jurisdiction: CA
Classification: —
Expires: 1995-01-24
Drug substance claim: No
Drug product claim: No
Assignee: EIDP Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.